GC
MRK icon

Grimes & Company’s Merck MRK Stock Holding History

Grimes & Company’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.3M Buy
41,284
+1,214
+3% +$142K 0.11% 117
2026
Q1 		$4.82M Buy
40,070
+13,747
+52% +$1.59M 0.13% 114
2025
Q4 		$2.77M Sell
26,323
-596
-2% -$55.9K 0.07% 168
2025
Q3 		$2.26M Buy
26,919
+2,727
+11% +$225K 0.06% 176
2025
Q2 		$1.92M Buy
24,192
+3,483
+17% +$277K 0.05% 167
2025
Q1 		$1.86M Sell
20,709
-949
-4% -$88.6K 0.06% 146
2024
Q4 		$2.15M Buy
21,658
+341
+2% +$35.2K 0.06% 147
2024
Q3 		$2.42M Sell
21,317
-427
-2% -$50.7K 0.07% 134
2024
Q2 		$2.69M Buy
21,744
+193
+0.9% +$24.9K 0.08% 121
2024
Q1 		$2.84M Sell
21,551
-281
-1% -$34.6K 0.09% 116
2023
Q4 		$2.38M Sell
21,832
-118
-0.5% -$12.2K 0.08% 126
2023
Q3 		$2.26M Buy
21,950
+4
+0% +$431 0.09% 115
2023
Q2 		$2.53M Sell
21,946
-246
-1% -$27.9K 0.09% 109
2023
Q1 		$2.36M Buy
22,192
+4,016
+22% +$434K 0.1% 107
2022
Q4 		$2.02M Buy
18,176
+449
+3% +$45.9K 0.09% 124
2022
Q3 		$1.53M Sell
17,727
-107
-0.6% -$9.55K 0.08% 119
2022
Q2 		$1.63M Buy
17,834
+214
+1% +$19K 0.08% 120
2022
Q1 		$1.45M Sell
17,620
-458
-3% -$36.1K 0.08% 133
2021
Q4 		$1.39M Sell
18,078
-586
-3% -$46.7K 0.06% 139
2021
Q3 		$1.4M Sell
18,664
-114
-0.6% -$8.67K 0.06% 135
2021
Q2 		$1.46M Sell
18,778
-696
-4% -$51.8K 0.06% 129
2021
Q1 		$1.43M Buy
19,474
+1,634
+9% +$121K 0.07% 124
2020
Q4 		$1.39M Sell
17,840
-325
-2% -$24.9K 0.07% 124
2020
Q3 		$1.44M Buy
18,165
+465
+3% +$36.4K 0.09% 113
2020
Q2 		$1.31M Buy
17,700
+105
+0.6% +$7.91K 0.09% 112
2020
Q1 		$1.29M Sell
17,595
-109
-0.6% -$8.57K 0.12% 100
2019
Q4 		$1.54M Buy
17,704
+5,471
+45% +$449K 0.1% 116
2019
Q3 		$983K Sell
12,233
-95
-0.8% -$7.61K 0.07% 130
2019
Q2 		$987K Sell
12,328
-316
-2% -$24.2K 0.07% 124
2019
Q1 		$1M Buy
12,644
+325
+3% +$24.3K 0.08% 118
2018
Q4 		$898K Sell
12,319
-169
-1% -$11.9K 0.09% 112
2018
Q3 		$845K Sell
12,488
-697
-5% -$44.4K 0.07% 127
2018
Q2 		$764K Sell
13,185
-35,421
-73% -$2M 0.07% 130
2018
Q1 		$2.53M Buy
48,606
+3,386
+7% +$183K 0.24% 85
2017
Q4 		$2.43M Sell
45,220
-613
-1% -$34K 0.23% 82
2017
Q3 		$2.8M Sell
45,833
-839
-2% -$50.9K 0.3% 75
2017
Q2 		$2.85M Sell
46,672
-2,564
-5% -$156K 0.32% 75
2017
Q1 		$2.98M Sell
49,236
-444
-0.9% -$26.9K 0.33% 75
2016
Q4 		$2.79M Sell
49,680
-121
-0.2% -$7.08K 0.32% 73
2016
Q3 		$2.97M Sell
49,801
-4,178
-8% -$244K 0.4% 69
2016
Q2 		$2.97M Buy
53,979
+45,002
+501% +$2.4M 0.4% 72
2016
Q1 		$453K Sell
8,977
-580
-6% -$28.4K 0.06% 127
2015
Q4 		$481K Buy
9,557
+493
+5% +$24.9K 0.07% 125
2015
Q3 		$427K Buy
9,064
+780
+9% +$41.4K 0.05% 122
2015
Q2 		$450K Sell
8,284
-647
-7% -$36.3K 0.06% 115
2015
Q1 		$489K Buy
8,931
+1,439
+19% +$81.5K 0.12% 98
2014
Q4 		$406K Buy
7,492
+128
+2% +$7.13K 0.1% 106
2014
Q3 		$416K Buy
7,364
+399
+6% +$22.4K 0.11% 103
2014
Q2 		$385K Buy
6,965
+1,230
+21% +$67.1K 0.1% 108
2014
Q1 		$311K Buy
5,735
+95
+2% +$4.92K 0.09% 113
2013
Q4 		$269K Buy
5,640
+660
+13% +$30.2K 0.08% 112
2013
Q3 		$226K Buy
+4,980
New +$227K 0.08% 118

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Grimes & Company's MRK Position: Q2 2026 in Review

Grimes & Company increased its Merck (MRK) stake by 3% in Q2 2026, buying an estimated $142K and bringing the position to 41,284 shares worth $5.3M. The position accounts for 0.11% of the portfolio, ranked #117.

Grimes & Company first reported a position in MRK in Q3 2013 and has held it in 52 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Grimes & Company held 41,284 shares of Merck worth $5.3M as of Q2 2026.
  • Grimes & Company bought 1,214 Merck shares in Q2 2026, an estimated $142K.
  • Merck made up 0.11% of Grimes & Company's portfolio in Q2 2026, its #117 holding.
  • Grimes & Company first reported a position in Merck in Q3 2013 and has held it in 52 quarters since.
  • 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.